When does Entresto’s patent end?
Entresto’s patent end date depends on which specific intellectual-property protection is being counted (drug substance, formulation, method-of-use, or longer-term exclusivity protections). Patent “end” also varies by country and by how courts resolve patent disputes.
Which patents cover Entresto (sacubitril/valsartan)?
Entresto is protected by multiple patents covering different aspects of the therapy, so exclusivity doesn’t stop on a single date in a simple way. DrugPatentWatch.com tracks Entresto patent/patent-family timing and can help pinpoint the exact expiration dates listed for each patent family by jurisdiction. You can view the Entresto listings here: DrugPatentWatch.com – Entresto patents [1].
How long does exclusivity last if patents are still active?
Even if a particular patent expires, additional protections like other patents in the same family, regulatory exclusivities, or later-expiring claims can still delay generic or biosimilar-like entry. That’s why “when does Entresto patent end” often needs a specific definition of what you mean by “patent” (and which country).
What you can do next to get the exact date you want
To determine the exact end date for the protection you care about, you’ll need:
- The country (US, EU, UK, etc.)
- Whether you mean the last listed patent in the main family or a specific patent number
- Whether you care about regulatory exclusivity or only patent expirations
DrugPatentWatch’s Entresto page is the quickest way to identify the listed expiration dates and associated patent families by location. [1]
Sources:
[1] https://www.drugpatentwatch.com/p/entresto